Gefitinib [gefitinib]
topical
49
- Terms
-
Iressa
-
Iressa
N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamide
ZD 1839
ZD1839
Persistent link
https://www.medvik.cz/link/D000077156
Definition
A selective tyrosine kinase inhibitor for the EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) that is used for the treatment of locally advanced or metastatic NON-SMALL CELL LUNG CANCER.
- DUI
- D000077156 MeSH Browser
- CUI
- M0444984
- History note
- 2019 (2001)
- Public note
- 2019; GEFITINIB was indexed under QUINAZOLINES 2001-2018
Allowable subheadings
- AD
- administration & dosage 3
- AE
- adverse effects 1
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics 1
- PD
- pharmacology 4
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 8
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records